0.270期刊基本信息
- ISSN： 0741-238X
- 是否OA： 否
- 发刊频率： 月刊
- 创刊时间： 2000
- 出版语言： English
- 出版地区： Springer Healthcare
- 出版商： ENGLAND
疗法的进步是一个国际同行评审,rapid-publication(3 - 4周发表的同行评审在两周内接受)杂志致力于出版高质量的临床(所有阶段),观察,真实,和健康结果的研究发现,开发和使用治疗和干预措施在所有治疗领域(包括设备)。研究有关诊断和诊断、药物经济学、公共卫生、流行病学、生活质量,和病人护理、管理和教育也是鼓励。《华尔街日报》感兴趣的观众广泛的医疗保健专业人士和出版原创性研究,评论、通讯和信件。《华尔街日报》阅读全球观众和接收提交来自世界各地。治疗的进步将考虑所有科学合理的研究是积极的,确认或负面数据。欢迎提交是否与国际和/或国家的观众,是至关重要的研究人员正试图目标更具体的患者群体。这种包容性的方法允许《协助所有从科学和伦理的声音的传播研究。
Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.
{{ c.comment }}